|
|
|
|||||
Archive:
| |||||
5, 1998) An unusual enzyme never before seen in viruses appears to shield an AIDS-related skin disease virus from the ravages of ultraviolet (UV) radiation and the immune system, according to a study by NIAID. (Aug. (Science Daily)
HIV persists in the gut despite long-term HIV therapy Feb 14, 2008
Because of the importance of the gut to HIV disease, scientists hoped that long-term treatment with antiretroviral drugs could eradicate HIV from the GALT. A new NIAID study, published online by The Journal of Infectious Diseases, has found that this goal seems unlikely with current antiretroviral drugs ... D., of the NIAID Laboratory of Immunoregulation (LIR), Anthony S. Fauci, M.D., LIR chief and NIAID director, and their colleagues intensively studied eight patients receiving effective... (EurekAlert!)
Plan Expedites Alternatives To Animal Testing Feb 13, 2008
(May 10, 2001) National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., unveiled the Institute s global plan to combat three leading infectious killers. The NIAID Global. (Science Daily)
12-Year-Old Haddon Twp. Girl Dies of Meningitis Feb 12, 2008
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced that the identification of a specific HIV receptor that. esearchers at the Purdue University in Indiana found that artificial sweeteners might contribute more to weight gain than food rich in sugar. (eFluxMedia)
NIAID scientists identify new cellular receptor for HIV Feb 10, 2008
Contact: NIAID Office of Communications ... A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system, according to researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) ... The identification of this new receptor opens up new avenues of investigation that may help further elucidate the complex mechanisms of the... (EurekAlert!)
How Poxviruses Such As Smallpox Evade The Immune System Feb 2, 2008
28, 2005) Mice given a relatively new cancer drug can survive an otherwise lethal dose of vaccinia virus, a relative of smallpox virus, report scientists supported by NIAID. The findings, say the. (Nov. (Science Daily)
Studies highlight MRSA evolution and resilience Jan 22, 2008
The study, from the National Institute of Allergy and Infectious Diseases (NIAID) of NIH, resolves debate about the molecular evolution of CA-MRSA in the United States ... A second study led by the same NIAID scientists takes the issue of the evolution of MRSA a step further, revealing new information about how MRSA bacteria in general, including the USA300 group, elude the human immune system ... D., at NIAIDs Rocky Mountain Laboratories (RML) in Hamilton, Mont. (EurekAlert!)
Discovery Opens Door To 'Personalized' Asthma Therapy Jan 20, 2008
17, 2003) In a finding that could have important implications for the millions of Americans who suffer from asthma, researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID) have. . (Science Daily)
New Picture Of HIV-1's Protein Jacket Identifies Target For Antibody-based Vaccine Jan 12, 2008
20, 2007) In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the NIAID have generated an atomic-level picture of a key portion of an HIV surface protein as. (Mar. (Science Daily)
Smallpox Vaccine Alternative Identified Jan 10, 2008
The animal tests were done by the NIAID, and human studies were held at Saint Louis University. The NIH supported the study. (Science Daily)
Poor Americans Suffer Hidden Burden Of Parasitic And Other Neglected Diseases Jan 2, 2008
1, 2008) Large numbers of the poorest Americans living in the United States are suffering from some of the same parasitic infections that affect the poor in Africa, Asia, and Latin America, says the Editor-in-Chief of PLoS Neglected Tropical Diseases. In an article entitled "Poverty and Neglected Diseases in the 'Other' America," Professor Peter Hotez (George Washington University and the Sabin Vaccine Institute) says that there is evidence that the parasitic diseases toxocariasis, cysticercosis... (Science Daily)
St. Lucie sex-ed plan riles foes Dec 4, 2007
Revised sex-ed proposal riles opponents in St. Lucie. Revised sex-ed proposal riles opponents in St. Lucie. (The Palm Beach Post)
Poxvirus' Ability To Hide From The Immune System May Aid Vaccine Design Nov 20, 2007
28, 2005) Mice given a relatively new cancer drug can survive an otherwise lethal dose of vaccinia virus, a relative of smallpox virus, report scientists supported by NIAID. The findings, say the. (May 1, 2007) In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune. (Science Daily)
UM medical school wins federal funding for vaccine development Nov 20, 2007
The grant from NIAID, which is part of the Bethesda-based , will be spread out over seven years. The money was awarded to the School of Medicine's Center for Vaccine Development. (Baltimore Business Journal, MD)
New Vaccine That Protects Monkeys Against Avian Flu Ready For Human Trials Nov 10, 2007
25, 2005) Fast-track recruitment has begun for a trial to investigate the safety of a vaccine against H5N1 avian influenza, the National Institute of Allergy and Infectious Diseases (NIAID), part of the. (Nov. (Science Daily)
HIV Vaccine Not Effective, More Research Needed Nov 9, 2007
NIAID and its study partners, Merck & Co., Inc., and the HIV Vaccine Trials Network (HVTN), fully recognize the importance of these results to the volunteers who participated in the study and the larger scientific community. The failure of this HIV vaccine product was a disappointment. (Science Daily)
The release of new data from the HVTN 502 HIV vaccine study Nov 8, 2007
Contact: NIAID News Office ... NIAID and its study partners, Merck Inc., and the HIV Vaccine Trials Network (HVTN), fully recognize the importance of these results to the volunteers who participated in the study and the larger scientific community ... Media inquiries can be directed to the NIAID News and Public Information Branch at 301-402-1663. (EurekAlert!)
Children Would Need Different Medical Care In Wake Of Dirty Bomb Nov 1, 2007
26, 2006) The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has issued five awards totaling 4 million to fund the development of products. (Apr. (Science Daily)
Study finds genetic influence on pace of HIV/AIDS progression Oct 23, 2007
Contact: NIAID News Office ... The study was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health ... SPOKESPERSONS: Anthony S. Fauci, M.D., NIAID Director, and Opendra Sharma, Ph. (EurekAlert!)
West Nile Virus' Spread Through Nerve Cells Linked To Serious Complication Oct 21, 2007 How To Assess Benefits Of Influenza Vaccine In The Elderly Sep 28, 2007 New national study links asthma to allergies Sep 28, 2007 NIH scientists describe ways to better assess benefits of influenza vaccine in the elderly Sep 25, 2007 Job's Syndrome Cause Identified Sep 23, 2007 2007 Lasker Awards announced Sep 18, 2007 Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug Sep 10, 2007 Protect Your Family During Mosquito Season Aug 30, 2007 Scientists seek better tests for Lyme Aug 15, 2007 Memphis lab awarded $12.2M to produce vaccines Aug 9, 2007 Free at last Aug 2, 2007 Early Treatment Prolongs Survival in HIV Babies Jul 26, 2007 First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines Jul 20, 2007 Safety of new microbicide for HIV prevention to be tested in young women in US trial Jul 10, 2007 Human Antibodies That Block Human And Animal SARS Viruses Identified Jul 5, 2007 Tamiflu(R) 30 mg and 45 mg Capsules Approved by U.S. Food and Drug Administration Jul 3, 2007 Ancient virus resistance came at modern cost Jun 25, 2007 NIAID releases MDR/XDR Tuberculosis research agenda Jun 7, 2007 Innovative Smallpox Vaccine Research Study To Be Conducted At Case Medical Center Jun 6, 2007 Health officials renew Indo-US Vaccine Action Program May 9, 2007 New virus discovered Apr 24, 2007 U.S. Approves 1st Bird Flu Vaccine Apr 19, 2007 Rapid response was crucial to containing the 1918 flu pandemic Apr 3, 2007 Genetically-Modified Mosquitoes May Uproot Malaria Mar 21, 2007 NIH researchers discover protein that appears to regulate bone mass loss, the cause of osteoporosis Mar 6, 2007 Review of 1918 pandemic flu studies offers more questions than answers Mar 1, 2007 Fighting the common cold Feb 25, 2007 Scientists Unveil Piece Of HIV Protein That May Be Key To AIDS Vaccine Development Feb 22, 2007 2,000 influenza virus genomes now completed and publicly accessible Feb 22, 2007 Global Study Concludes 'Attack Rate' Of Flu In Kids Is 55 Percent Lower With Nasal Spray Vaccine Feb 17, 2007 AIDS Virus Weakness Detected Feb 17, 2007 Scientists expose HIV weak spot Feb 15, 2007 New study may show how to forestall a fatal, virus-caused immune-system meltdown Feb 15, 2007 Fighting Influenza And Company With 40,000 Blood Samples Feb 9, 2007 First Large-scale HIV Vaccine Trial In South Africa Opens Feb 9, 2007 Immune Molecule Protects Cells Threatened by HIV Feb 8, 2007 Discovery could lead to better control of hemorrhagic fever viruses Feb 8, 2007 Flat NIH funding again in '08 Feb 7, 2007 Changes In Amino Acids In 1918 Influenza Virus Cut Transmission Feb 7, 2007 AIDS pioneer new star witness Feb 7, 2007 Scientists explore new avenue in AIDS fight Feb 6, 2007 Organization Halts Clinical Trial For Potential Microbicide For Preventing HIV Infection Feb 3, 2007 Disabling Key Protein May Give Physicians Time To Treat Pneumonic Plague Jan 28, 2007 Tuberculosis intervention program improves patient outcomes Jan 26, 2007 New Culture Method For Hepatitis C Virus Uses Primary Hepatocytes And Patient Serum Jan 24, 2007 Inhaled steroids best treatment for children with asthma Jan 24, 2007 Carbon Monoxide Protects Lung Cells Against Oxygen-induced Damage Jan 21, 2007 Programmed Cell Death Protects Against Infections Jan 16, 2007 Scientists sequence genome of parasite responsible for common sexually transmitted infection Jan 13, 2007 New U.S. biodefense agency signed into law Jan 12, 2007 NIAID DNA vaccine for H5N1 avian influenza enters human trial Jan 4, 2007 K'la Men Rush to Get Circumcised Jan 4, 2007 Newly Identified Strains Of Chlamydia Trachomatis Could Produce New Diseases Jan 3, 2007 LIAI completes world's most comprehensive analysis on influenza virus data Jan 2, 2007 New details on how the immune system recognizes influenza Jan 2, 2007
19, 2003) Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) have created a promising vaccine against West Nile virus by replacing parts of a distantly related virus with proteins. (Mar. (Science Daily)
Cat Allergy Linked to Asthma Oct 1, 2007
Along with researchers from the National Institute of Allergy and Infectious Diseases (NIAID), Zeldin and NIEHS colleagues examined skin test data for 10 common allergens from a nationally representative sample of 10,508 people between the ages of 6 and 59 ... "This study tells us that allergy is a major factor in asthma," Peter Gergen, MD, MPH, of the NIAID says in a news release ... Darryl C. Zeldin, MD, senior investigator, National Institute of Environmental Health Sciences, National... (WebMD)
Better vaccines are needed, however, and NIAID supports research to develop new and improved vaccines ... D., formerly of the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. Other authors include Mark A. Miller, M.D., of NIH's Fogarty International Center, and Lisa A. Jackson, M.D., of Group Health Center for Health Studies, Seattle. (Science Daily)
Each of 10 allergen-specific skin tests was strongly associated with asthma; however, after adjustment by a variety of subject characteristics and all the allergens, only skin tests to cat, Alternaria and white oak were independently and positively associated with asthma, said Peter Gergen, M.D., M.P.H, of NIAID's Division of Allergy, Immunology and Transplantation, a co-author on the paper ... NIAID is a component of the National Institutes of Health, an agency of the U.S. Department of Health... (EurekAlert!)
Contact: NIAID News Office ... Better vaccines are needed, however, and NIAID supports research to develop new and improved vaccines ... D., formerly of the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. Other authors include Mark A. Miller, M.D., of NIHs Fogarty International Center, and Lisa A. Jackson, M.D., of Group Health Center for Health Studies, Seattle. (EurekAlert!)
"Understanding the genetic cause of this rare immunological disorder is a signal accomplishment, revealing information that has been sought for decades," says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), a component of NIH. "The immunological insights from this study not only promise to open new therapeutic doors for Job's syndrome, but also provide new leads for treating other immunodeficiency diseases." ... Steven M. Holland, M.D.,... (Science Daily)
the director of the, NIAID will receive the award for his work orchestrating the $15 billion (PEPFAR) program, which supports 114 countries in creating prevention, treatment and care plans for the disease. Fauci recognized HIV as major public health crises when it first emerged in the 1980s. (The Scientist)
This unique new chemical entity is referred to as compound NIAID #11039 ... "Already, Chinese scientists are very interested." Dr. Hershline hosted Session V at the World Aids Day Conference China Dec 1 to Dec 3, 2006, to initially present data an NIAID #11039 ... "The substitution groups are different sulfur based viral de-activating groups that work together to provide viral entry inhibition at concentrations of one pico-Molar. This active concentration is equivalent to diluting a 1% solution... (PR Newswire)
And according to the National Institute of Allergy and Infectious Diseases (NIAID), more than 100,000 cases of Lyme disease have been reported here. Traditional insect repellents can be effective, but the potential health risks-especially to children-have many parents thinking twice about slathering man-made chemicals on their kids' clothing, arms, legs and faces. (Sebastopol Sonoma West Publishing, CA)
- Serving York, Chester, and Lancaster Counties. Wednesday, August 15, 2007. (Herald Online, SC -- Health)
Meridian will be working closely with the Laboratory of Infectious Diseases of the NIAID, which has a long history of vaccine development and identification of new agents of viral diseases. The experimental vaccines will ultimately be used for the prevention of viral diseases in humans, said Meridian's life science president Richard L. Eberly. (Memphis Business Journal, TN)
Defence Science and Technology Laboratory. Salisbury, United Kingdom. (Nature News Service)
The study, by the U.S. National Institute of Allergy and Infectious Disease (NIAID), was so successful that it was cut short by four years so that all children could receive treatment ... "The results of this trial could have significant public health implications worldwide because these findings will cause experts to consider changes in standards of care in many parts of the world," said NIAID director Dr. Anthony Fauci. (MEDLINEplus)
CHAVI, which is led by Barton Haynes, M.D., of Duke University, Durham, N.C., was established in 2005 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. ... CHAVI is designed to foster collaborative research to overcome roadblocks that have impeded HIV vaccine development, says NIAID Director Anthony S. Fauci, M.D. The insights into genetic factors influencing host control of HIV revealed by this work exemplify the power of such collective investigations ...... (EurekAlert!)
Included in its research portfolio are two ongoing trials that, until 2006, were part of NIAIDs HIV Prevention Trials Network (HPTN) ... The Microbicide Trials Network (MTN) is an HIV/AIDS clinical trials network established in 2006 by the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) ... It receives its funding from three NIH institutes: NIAID, the National Institute of Mental Health and the National... (EurekAlert!)
The research team was led by scientists from the National Cancer Institute (NCI) and the National Institute of Allergy and Infectious Diseases (NIAID), both parts of the National Institutes of Health, and included collaborators from the U.S. Army (USAMRIID), academic institutions in the United States, Switzerland, and Australia ... "This study is important because the viral strain that caused the outbreak in people in 2002 probably no longer exists in nature," explains Kanta Subbarao, M.D.,... (Science Daily)
(2) Children are also two to three times more likely than adults to get sick with the flu, according to the National Institute for Allergies and Infectious Diseases (NIAID). (3) Additionally, children represent one of the most important links in influenza transmission. (PR Newswire)
Sign up to receive our free Tech e-newsletter and get the top news of the day in your inbox. Get breaking news in your inbox as it happens. (USA Today -- Tech)
WHAT: The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), today released its NIAID Research Agenda for Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Tuberculosis (TB) ... The research priorities identified in the agenda build on a foundation of ongoing NIAID-supported TB research, which currently comprises more than 300 research projects worldwide ... According to NIAID Director Anthony S. Fauci, M.D., NIAID... (EurekAlert!)
UHCMC and the School of Medicine will act as a subunit of St. Louis University's Center for Vaccine Development, which is one of seven national testing sites known as Vaccine and Treatment Evaluation Units (VTEUs), designated by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The research study, which is actively recruiting and begins here June 15, will follow 215 volunteers nationwide over a two-year period. (Science Daily)
Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and Roger Glass M.D., Ph ... On behalf of the U.S. government, NIAID manages the VAP and has provided scientific guidance since its inception ... NIAID is a component of the National Institutes of Health. (EurekAlert! -- Business News)
Contact: NIAID News Office ... So the Australian team turned to scientists at the Greene Infectious Disease Laboratory of the Mailman School of Public Health of Columbia University, who have been developing new techniques for diagnosing infectious diseases with funds from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health ... SPOKESPERSON: NIAID Director Anthony S. Fauci, M.D., is available to comment on the discovery. (EurekAlert!)
"Having a vaccine that would require 90 micrograms twice, in and of itself, would not and could not be the answer to where we want to be," Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID), said when the New England Journal article was published ... The study was funded by NIAID.. (MEDLINEplus)
These important papers suggest that a primary lesson of the 1918 influenza pandemic is that it is critical to intervene early, says Anthony S. Fauci, M.D., director of NIHs National Institute of Allergy and Infectious Diseases (NIAID), which funded one of the studies ... The first of the two historical studies, conducted by a team of researchers from NIAID, the Department of Veterans Affairs, and the Harvard School of Public Health, looked at 19 different public health measures that were... (EurekAlert!)
Ever since scientists at the National Institute of Allergy and Infectious Diseases (NIAID) mapped out a high-resolution genetic map of Plasmodium falciparum in 1999, scientists have thought about genetically modifying mosquitoes to bar entry of the malarial parasite. Marcelo Jacobs-Lorena and colleagues have realized that strategy. (News Locale)
Now researchers at the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), and colleagues are reporting new insights into the biology of bone loss based on a study of 14 people with a rare genetic disorder called X-linked Hyper IgM Syndrome ... Last year, an NIAID doctor treating children with this disease observed that several of them sustained unexplained rib fractures that he hypothesized could be, like osteoporosis, caused by a loss... (EurekAlert!)
Contact: NIAID News Office ... However, in a Journal of Infectious Diseases review article now posted online, David M. Morens, M.D., and Anthony S. Fauci, M.D., of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, conclude that studies of the 1918 influenza pandemic, which killed some 50 to 100 million people around the globe, have so far raised more questions than they answer ... "Today, nearly a century after the 1918 influenza... (EurekAlert!)
Adults, says the NIAID, a division of the National Institutes of Health, should expect the effects of a cold to linger a week or two ... In fact, according to the NIAID, cold season begins around Labor Day, intensifies during the winter months, then declines around the start of spring ... The NIAID says the increase may have more to do with incidental factors: School brings large numbers of kids together, and people spend more time indoors in the winter, in closer proximity to folks who might be... (The Standard-Times, MA)
In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have generated an atomic-level picture of a key portion of an HIV surface protein as it looks when bound to an infection-fighting antibody ... D., of NIAID's Vaccine Research Center (VRC) ... His collaborators included other scientists from NIAID and the National Cancer... (Science Daily)
The Influenza Genome Sequencing Project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), announced today that it has achieved a major milestone ... "Scientists around the world can use the sequence data to compare different strains of the virus, identify the genetic factors that determine their virulence, and look for new therapeutic, vaccine and diagnostic targets," says NIAID Director Anthony S. Fauci, M.D. ... The... (EurekAlert!)
(February 16, 2000) -- An experimental nasal spray flu vaccine protected young children against an influenza strain not covered by the vaccine, according to results from the second year of a study supported by NIAID and ... (February 9, 2000) -- An experimental nasal spray flu vaccine protected young children against an influenza strain not covered by the vaccine, according to results from the second year of a study supported by NIAID and. (Science Daily)
NIAID Director Dr. Anthony Fauci said the findings are of great importance, but much more work in animal and human studies is needed, and any vaccine is years away. "I don't think there's any one particular thing that, in and of itself, is the show-stopper. But I don't think we could really make substantial, fundamentally scientifically based progress until we got this very important information," he said. (MEDLINEplus)
" Slippery foe Developing a vaccine for HIV has proved extremely difficult. The virus is able to mutate rapidly to avoid detection by the immune system, and is also swathed by a near-impenetrable cloak of sugary molecules which block access by antibodies. But certain parts of the virus must remain relatively unchanged so that it can continue to bind to and enter human cells. A protein, gp120, that juts out from the surface of the virus and binds to receptors on host cells, is one such region,... (BBC News -- UK)
He noted that the Lassa, Ebola and Marburg fever viruses have been identified as Category A biothreat agents by the National Institute of Allergy and Infectious Diseases (NIAID) ... Funding for the investigation was provided by the Defense Advanced Research Projects Agency, the National Institutes of Health, and the NIAIDs Western Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research. (EurekAlert!)
(August 20, 1998) -- Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) have discovered why some influenza viruses are uncommonly deadly. In a paper published in the Aug. 18 issue. (Science Daily)
Conducted jointly by the South African AIDS Vaccine Initiative (SAAVI) and the HIV Vaccine Trials Network (HVTN), the trial is supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) ... "We applaud the South Africans for bringing this important trial to fruition. This international partnership exemplifies the model of collaboration needed to defeat HIV/AIDS," says NIAID Director Anthony S. Fauci, M.D. ... (September 11,... (Science Daily)
"It's not just the drugs that battle HIV," says researcher Paolo Lusso, a virologist and immunologist at the National Institute of Allergy and Infectious Disease (NIAID) ... Lusso, together with leading HIV researcher and NIAID chief Anthony Fauci and their colleagues, added IL-7 to T cells extracted from people at different stages of HIV infection. (Scientific American)
All four are classified as NIAID Category A Priority Pathogens and must be handled in Biosafety Level 4 containment facilities. The researchers, led by Hyeryun Choe, PhD, of Children's Hospital Boston's Pulmonary Division, and Michael Farzan, PhD, of Harvard Medical School (HMS), first investigated the Machupo virus. (EurekAlert!)
4 percent, with the major exception being the National Institute of Allergy and Infectious Diseases (NIAID), whose funding would increase by 4. 8 percent -- or $210 million -- to $4. (The Scientist)
Modest changes in the 1918 flu virus's hemagglutinin receptor binding site--a molecular structure critical for the spread of infection--stopped viral transmission in ferrets, according to a new study conducted by researchers at Mount Sinai School of Medicine and at the Centers for Disease Control and Prevention. The finding, published in the February 1 issue of Science, could have significant clinical implications in helping scientists develop ways to break the disease cycle and possibly help... (Science Daily)
Bennet said that he has knowledge of HIV's ability to kill T-cells, well that's just amazing since anyone can visit the NIAID website and read "How HIV Causes AIDS" and see that the US government is not even making similar claims. There is still no definition of how HIV might kil T-cells or any kind of cells. (Advertiser Adelaide)
The researchers, who also included Dr. Lia Vassena and NIAID Director Dr. Anthony Fauci, used blood samples from 24 HIV-infected people. They added interleukin 7 to the blood samples and then gauged the survival of T cells. (MSNBC -- Health)
(September 11, 2003) -- The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has reached a milestone in its efforts to support accelerated development of malaria ... (October 18, 2005) -- A novel vaccine targeted to multiple HIV subtypes found worldwide has moved into the second phase of clinical testing, the National Institute of Allergy and Infectious Diseases (NIAID), part of the. (Science Daily)
(Credit: Rocky Mountain Laboratories, NIAID, NIH). Speed is a primary concern in pneumonic plague, which kills in three to four days and potentially could be used in a terrorist attack. (Science Daily)
NIAID supports not only studies to better understand how M. tuberculosis. - Tuberculosis and Respiratory Protection: prohibition on enforcement of annual fit. (SpiritIndia)
(September 2, 1997) -- Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Md. have identified a strain of hepatitis E virus in pigs that is very similar to the strain that. (Science Daily)
The issue features review articles on several NHLBI programs the Asthma Clinical Research Network, the Childhood Asthma Research and Education Network, the Childhood Asthma Management Program, and the Severe Asthma Research Program as well as the Asthma and Allergic Diseases Research Centers and the Inner City Asthma Consortium of the National Institute of Allergy and Infectious Diseases (NIAID) ... NIAID spokespersons are available to comment on the NIAID-funded Asthma and Allergic Diseases... (EurekAlert!)
(May 3, 2005) -- Research performed at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has revealed that oxygen therapy aimed at helping mice with acute. . (Science Daily)
(August 29, 2003) -- Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have discovered how Streptococcus pyogenes (S. pyogenes), the. . (Science Daily)
The genome sequencing project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is detailed in the January 12 issue of Science ... "By better understanding the genetic makeup of the Trichomonas vaginalis parasite that causes trichomoniasis, we can target our efforts to developing the most effective medicines to treat the infection and potentially create a way to prevent infection altogether," says NIAID Director Anthony... (EurekAlert!)
"So I really look at it very much so as a complimentary thing, not that they're going to be encroaching on our turf at all," said Tony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID). Since September 11, 2001, NIAID has been in charge of deciding what basic bioterror research the nation will fund ... Burr, NIAID will keep that role, and the BARDA director will be "much more of a requirements-driven person," creating products public health officials want. (The Scientist)
Contact: NIAID News Office ... The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the NIH Institutes, designed the vaccine ... "An effective H5N1 influenza vaccine would... (EurekAlert!)
The study, carried out by the National Institute of Allergy and Infectious Diseases (NIAID), was done in Rakai, Uganda and Kisumu in Kenya ... The new controversy surrounding circumcision follows the US National Institute of Allergy and Infectious Diseases (NIAID)'s halting two random clinical trials of adult male circumcision. (AllAfrica.com)
(October 23, 1998) -- Researchers in California supported by the National Institute of Allergy and Infectious Diseases (NIAID) have completed sequencing the Chlamydia trachomatis genome, providing new insights into. . (Science Daily)
The study, using information from a worldwide research database funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), provides an important tool for scientists seeking to develop vaccines and therapies against both seasonal and pandemic influenza strains, including the deadly H5N1 avian flu ... The study looked at all scientific data on influenza A virus antibody and T cell epitopes published to date worldwide, drawing from... (EurekAlert!)
Drawing upon a massive database established with funds from the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), scientists have completed the most comprehensive analysis to date of published influenza A virus epitopes--the critical sites on the virus that are recognized by the immune system ... "This study is interesting for what it shows we know and do not know," says NIAID Director Anthony S. Fauci, M.D. "It reveals many gaps in... (EurekAlert!)
Back to Health News
©1998-2008 SurfWax, Inc.
All rights reserved. Patents pending.
Copyright SurfWax, Inc. 2008 |